Anterix Q2 Adj EPS $(0.27) Beats $(0.62) Estimate, Sales $1.05M Miss $1.08M Estimate
Portfolio Pulse from bharat@benzinga.com
Anterix reported Q2 adjusted EPS of $(0.27), surpassing the $(0.62) estimate, marking a 51.79% improvement from last year. However, sales of $1.05M fell short of the $1.08M estimate, despite a 164.32% increase from the previous year.
November 13, 2023 | 10:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Anterix outperformed EPS estimates but slightly missed revenue expectations, showing significant improvement in losses and a sharp increase in sales year-over-year.
While Anterix beat EPS estimates significantly, which is a positive indicator, the slight miss on revenue estimates may temper investor enthusiasm. The substantial year-over-year growth in sales and reduction in losses are likely to be viewed positively, but the mixed results could lead to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100